Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (GU5) - Total Liabilities

Latest as of March 2026: €47.87 Billion EUR ≈ $55.96 Billion USD

Based on the latest financial reports, Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (GU5) has total liabilities worth €47.87 Billion EUR (≈ $55.96 Billion USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Guangzhou Baiyunshan Pharmaceutical Hold equity growth rate to track the company's year-over-year net asset growth rate.

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited - Total Liabilities Trend (2013–2025)

This chart illustrates how Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited's total liabilities have evolved over time, based on quarterly financial data. See Guangzhou Baiyunshan Pharmaceutical Hold free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Competitors by Total Liabilities

The table below lists competitors of Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited ranked by their total liabilities.

Company	Country	Total Liabilities
Kaveri Seed Company Limited NSE:KSCL	India	Rs8.42 Billion
Fujian Minfa Aluminium Co Ltd SHE:002578	China	CN¥737.45 Million
Beijing Hezong Science&Technology Co Ltd SHE:300477	China	CN¥5.13 Billion
Shinhan Alpha REIT Co Ltd KO:293940	Korea	₩2.33 Trillion
Hubei Xiangyuan New Material Technology Inc. SHE:300980	China	CN¥122.06 Million
Israel Land Development Company Co Ltd TA:ILDC	Israel	ILA7.45 Billion
Lion Travel Service Co Ltd TW:2731	Taiwan	NT$8.20 Billion
Foseco India Limited NSE:FOSECOIND	India	Rs-11.20 Billion

Liability Composition Analysis (2013–2025)

This chart breaks down Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see GU5 company net worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.60	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	1.21	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.53	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (2013–2025)

The table below shows the annual total liabilities of Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited from 2013 to 2025.

Year	Total Liabilities	Change
2025-12-31	€44.43 Billion ≈ $51.94 Billion	+1.17%
2024-12-31	€43.91 Billion ≈ $51.34 Billion	+4.78%
2023-12-31	€41.91 Billion ≈ $49.00 Billion	+2.15%
2022-12-31	€41.03 Billion ≈ $47.97 Billion	+17.93%
2021-12-31	€34.79 Billion ≈ $40.67 Billion	+10.26%
2020-12-31	€31.55 Billion ≈ $36.89 Billion	+2.11%
2019-12-31	€30.90 Billion ≈ $36.13 Billion	+9.05%
2018-12-31	€28.34 Billion ≈ $33.13 Billion	+213.08%
2017-12-31	€9.05 Billion ≈ $10.58 Billion	+9.80%
2016-12-31	€8.24 Billion ≈ $9.64 Billion	+14.70%
2015-12-31	€7.19 Billion ≈ $8.40 Billion	+13.27%
2014-12-31	€6.34 Billion ≈ $7.42 Billion	+21.39%
2013-12-31	€5.23 Billion ≈ $6.11 Billion	--

About Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited

F:GU5 Germany Medical Distribution

Market Cap

$429.33 Million

€367.23 Million EUR

Market Cap Rank

#12963 Global

#1373 in Germany

Share Price

€1.67

Change (1 day)

-1.18%

52-Week Range

€1.55 - €2.30

All Time High

€2.30